evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/geneAliases/5,gene/geneAliases/6,gene/geneAliases/7,gene/geneAliases/8,gene/geneAliases/9,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract
13171,GENE_SUMMARY,,"PTPN11 encodes a protein tyrosine phosphatase involved in the RAS/MAPK pathway. Germline mutations of PTPN11 are associated with Noonan and LEOPARD syndromes, and somatic mutations are found in leukemias and several solid tumors.",,2017-04-06,,5781,PTPN11,"protein tyrosine phosphatase, non-receptor type 11",True,ENST00000351677,NM_002834.3,JMML,CFC,SHP2,PTP2C,2017-11-15T00:00:00,NS1,BPTP3,METCDS,SH-PTP3,SH-PTP2,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
13172,GENE_BACKGROUND,,"The PTPN11 gene encodes a proto-oncogene encoding Src homology-2 domain-containing phosphatase, known as SHP2 (PMID: 18286234). PTPN11 is a member of the protein-tyrosine phosphatase family of proteins (PMID: 18286234) and is comprised of three key domains: two SH2 domains (the N-terminal SH2 (N-SH2) and C-terminal SH2 (C-SH2) domains), and the protein tyrosine phosphatase (PTP) domain, followed by a proline-rich motif (PMID: 18286234). PTPN11 interacts with multiple cellular pathways and is required for activation of the RAS/MAPK pathway (PMID: 18286234). In its resting state, PTPN11 is suppressed by interactions between the N-SH2 domain and the PTP domain (PMID: 18286234). After growth factor or cytokine stimulation of a receptor tyrosine kinase (RTK), such as the platelet-derived growth factor receptor alpha (PDGFRA), PTPN11 is recruited to the phosphorylated tyrosine residue on the RTK (PMID: 18286234). This causes conformational changes in PTPN11 that releases the N-SH2 domain from the PTP domain, resulting in the disinhibition of PTPN11. The exact molecular targets that PTP dephosphorylates are controversial, but PTP activity is required for RAS/ERK pathway activation. PTPN11 also acts as a negative regulator of PIK3/AKT activation in the EGFR signaling cascade. PTPN11 interacts with several other oncogenic pathways in various cancer models (PMID: 14644997), including MAPK (PMID: 24618081), STAT5 (PMID: 23103841) and RAS/RAF/ERK signaling (PMID: 25026279). Germline mutations in PTPN11 cause Noonan syndrome and LEOPARD syndrome, while somatic mutations are present in leukemias and are prevalent in juvenile myelomonocytic leukemia (JMML) (PMID: 18286234, 16358218).",,2017-04-06,,5781,PTPN11,"protein tyrosine phosphatase, non-receptor type 11",True,ENST00000351677,NM_002834.3,JMML,CFC,SHP2,PTP2C,2017-11-15T00:00:00,NS1,BPTP3,METCDS,SH-PTP3,SH-PTP2,False,14644997,Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis.,Blood,2018-03-15T20:04:00,103,6,2325-31,Loh ML et al,,,0001-03-15,,24618081,The tyrosine phosphatase SHP2 is required for cell transformation by the receptor tyrosine kinase mutants FIP1L1-PDGFRα and PDGFRα D842V.,Molecular oncology,2018-05-01T20:14:00,8,3,728-40,Noël LA et al,doi: 10.1016/j.molonc.2014.02.003,,0001-05-01,,23103841,"The protein tyrosine phosphatase, Shp2, positively contributes to FLT3-ITD-induced hematopoietic progenitor hyperproliferation and malignant disease in vivo.",Leukemia,2018-02-01T20:13:00,27,2,398-408,Nabinger SC et al,doi: 10.1038/leu.2012.308,,2018-02-01T04:08:00,,18286234,The tyrosine phosphatase Shp2 (PTPN11) in cancer.,Cancer metastasis reviews,2018-06-01T20:08:00,27,2,179-92,Chan G et al,doi: 10.1007/s10555-008-9126-y,,0001-06-01,,16358218,Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease.,American journal of human genetics,2018-02-01T20:06:00,78,2,279-90,Tartaglia M et al,,,0001-02-01,,25026279,Oncogenic KIT-induced aggressive systemic mastocytosis requires SHP2/PTPN11 phosphatase for disease progression in mice.,Oncotarget,2018-08-15T20:14:00,5,15,6130-41,Sharma N et al,,,0001-08-15,
